Home

Mangalam Drugs And Organics Ltd PE Ratio

Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

PE

17.5

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Mangalam Drugs and Organics Ltd is 17.5 as of 15 Jan 13:19 PM .
  • The P/E Ratio of Mangalam Drugs and Organics Ltd is 0 as of March 2024 .
  • The Latest Trading Price of Mangalam Drugs and Organics Ltd is ₹ 106.55 as of 15 Jan 13:11 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

PE

-

Last updated on: Invalid Date

Company Fundamentals for Mangalam Drugs and Organics Ltd

Image

Mangalam Drugs and Organics Ltd

NSE: MANGALAM

Share Price

₹ 106.55

2.50 (2.40%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Mangalam Drugs and Organics Ltd

1M

1Y

3Y

5Y

Monitoring Mangalam Drugs and Organics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025104.05
13 Jan 2025101.95
10 Jan 2025111.65
09 Jan 2025115
08 Jan 2025112.3
07 Jan 2025114.5
06 Jan 2025111.3
03 Jan 2025118.35
02 Jan 2025120.65
01 Jan 2025119.85

SWOT Analysis Of Mangalam Drugs and Organics Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Mangalam Drugs and Organics Ltd

Asset Value vs Market Value of Mangalam Drugs and Organics Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Mangalam Drugs and Organics Ltd164.69
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Mangalam Drugs and Organics Ltd Explained

``

164.69

Market cap

9

Earnings

17.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Mangalam Drugs and Organics Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Mangalam Drugs and Organics Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Mangalam Drugs and Organics Ltd

No data available

* All values are in %

About Mangalam Drugs and Organics Ltd

  • Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
  • The company was promoted by Dhoot family.
  • The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
  • The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

Mangalam Drugs and Organics Ltd News Hub

Mangalam Drugs and Organics reports standalone net profit of Rs 2.68 crore in the June 2024 quarter

Net profit of Mangalam Drugs and Organics reported to Rs 2.68 crore in the quarter ended June 2024 a

Read more

2024-08-14 00:00:00

Mangalam Drugs and Organics to declare Quarterly Result

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 Augus

Read more

2024-08-10 00:00:00

Mangalam Drugs and Organics AGM scheduled

Mangalam Drugs and Organics announced that the 51th Annual General Meeting (AGM) of the company will

Read more

2024-09-25 00:00:00

Mangalam Drugs and Organics to table results

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 14 Novem

Read more

2024-11-08 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Mangalam Drugs and Organics Ltd

What is the current PE Ratio of Mangalam Drugs and Organics Ltd?

The Current PE Ratio of Mangalam Drugs and Organics Ltd is 17.52 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Mangalam Drugs and Organics Ltd last year?

The PE Ratio of Mangalam Drugs and Organics Ltd was 0.0 last year, now the PE ratio is 17.52, showing a year-on-year growth of -%.

What does the PE Ratio of Mangalam Drugs and Organics Ltd indicate about its stock?

The PE Ratio of Mangalam Drugs and Organics Ltd is 17.52. This ratio indicates that investors are willing to pay 17.52 times the earnings per share for each share of Mangalam Drugs and Organics Ltd.

What is the PE Ratio Growth of Mangalam Drugs and Organics Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Mangalam Drugs and Organics Ltd grew by -% whereas, the EPS ratio grew by 0.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions